Discover the precision and reliability of the Supreme Peptides PT-141 Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “PT-141” and contains a premium synthetic peptide with purity exceeding 99%, ensuring consistency and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on neuroendocrine signaling, motivation pathways, and sexual behavior research. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of handling in controlled research protocols.

PT-141 (Bremelanotide) is a synthetic melanocortin peptide analog derived from α-MSH and is widely studied for its effects on central nervous system pathways related to arousal, motivation, and behavioral response. Unlike peptides that act peripherally, PT-141 is primarily investigated for its central mechanism of action involving melanocortin receptors in the brain.

Product overview

PT-141 is a research peptide engineered to selectively activate melanocortin receptors, particularly MC3R and MC4R, which play key roles in neuroendocrine signaling and behavioral regulation. Preclinical and clinical research associate PT-141 with modulation of desire, motivation, and autonomic nervous system activity, making it a valuable tool for studies involving central arousal pathways and psychoneuroendocrinology.

Key research features

Central arousal and motivation pathways:
PT-141 is widely studied for its ability to influence brain-based arousal signaling independent of vascular mechanisms. Research models explore its role in motivation, reward circuitry, and behavioral responsiveness.

Neuroendocrine signaling research:
Studies suggest PT-141 may modulate hypothalamic and autonomic pathways involved in hormonal and behavioral regulation, supporting its use in experimental models of sexual function and CNS-driven response mechanisms.

Stress and autonomic response modulation:
Research indicates PT-141 may influence sympathetic and parasympathetic balance through central receptor activation, making it relevant for studies examining stress response, mood, and neurobehavioral interactions.

PT-141 Suggested Use:

• Typical Dose: 1–2 mg per injection

• Route: Subcutaneous

• Frequency: As needed, up to once daily

• Duration: Short-term use, or as recommended by a healthcare professional

Note: Always consult a healthcare professional before use. Keep out of reach of children.

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.